Pharmaceutical Drug Targets and Diseases: Difference between revisions
Jump to navigation
Jump to search
David Canner (talk | contribs) No edit summary |
David Canner (talk | contribs) No edit summary |
||
Line 173: | Line 173: | ||
****[[User:Tsung-Yi_Lin/Sandbox|HIV-1 Protease Analysis]] | ****[[User:Tsung-Yi_Lin/Sandbox|HIV-1 Protease Analysis]] | ||
****[[HIV-1 Gag]] | ****[[HIV-1 Gag]] | ||
****[[1gwp|HIV-1 Gag N-terminal Domain]] | |||
****[[HIV-1 Gag Recruitment of Tsg101 and the Viral Budding Process]] | ****[[HIV-1 Gag Recruitment of Tsg101 and the Viral Budding Process]] | ||
****[[HIV-1 NEF]] | ****[[HIV-1 NEF]] |
Revision as of 15:38, 30 September 2010

The following is a list of major pharmaceutical compound targets, drugs, and information organized by disease.